Medical/Pharmaceuticals
Dr Ivan Puah, Liposuction Doctor In Singapore, Shares The Secret To Achieving A Good Liposuction Result
Liposuction is more than just what meets the eye. It is a procedure that combines science and art. SINGAPORE, Oct. 12, 2022 /PRNewswire/ -- Liposuction continuously ranks as one of the most preferred fat removal options. Its efficacy, however, does not reflect the intricacies and complexiti...
2022-10-12 11:38
2629
WuXi Biologics and Toregem BioPharma Sign MOU for Development of Anti-USAG-1 Antibody
SHANGHAI, Oct. 11, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), and Toregem BioPharma, a biotech startup company fromKyoto University, today announced that they have signed a Memorandum of Under...
2022-10-12 09:00
3448
TVM Capital Healthcare and Siemens Healthineers announce strategic collaboration to advance healthcare access in Southeast Asia
The alliance aims to combine forces of healthcare specialist investor TVM Capital Healthcare and leading Medtech company Siemens Healthineers, to ensure patients' improved access to quality and affordable healthcare services and accelerate sustainable growth for healthcare providers acrossSouthea...
2022-10-12 08:00
2755
Ascend continues broad expansion into new markets, launches HiDura™ MED portfolio
HOUSTON, Oct. 12, 2022 /PRNewswire/ -- Ascend Performance Materials today
announced a new portfolio of medical grade nylon 6,6 resins and engineered
materials for the healthcare market under itsHiDura™ brand.
2022-10-12 00:20
3960
CSafe and BioLife Solutions, Inc. announce partnership to expand supply chain solutions for the cell and gene therapy market
CSafe joins BioLife's global partner network of cold chain solution providers using the evo® cold chain management platform MONROE, Ohio and BOTHELL, Wash., Oct. 11, 2022 /PRNewswire/ -- CSafe, one of the largest active and passive temperature-controlled shipping solutions providers for pharmace...
2022-10-11 22:10
5140
Integrating Fitbit & MindFi App into Daily Lifestyle Leads to Significant Improvements in Teachers' Mental Wellness - Singapore Study
SINGAPORE, Oct. 11, 2022 /PRNewswire/ -- Regular use of a mental wellness app solution combined with Fitbit wearable devices to track activity and sleep can have a positive impact on users' physical and mental health, according to a new pilot study involvingSingapore teachers. After a challeng...
2022-10-11 17:13
3923
Pharming submits a Marketing Authorisation Application to the European Medicines Agency for Leniolisib
Application is based on randomized, controlled and long-term extension data for leniolisib as a treatment for APDS, a rare primary immunodeficiency This submission follows the grant of accelerated assessment allowing an expedited review for leniolisib from a standard 210 days to 150 days LEIDEN...
2022-10-11 13:00
2727
Anti-Oxidant Extracts from Young Durians - Potential Value-Added Cosmetics from Agricultural Waste by Chula
Chula Faculty of Science researchers find young durian extracts to have as high anti-oxidants as vitamin C and aim to produce skin care products that add value to agricultural waste. BANGKOK, Oct. 11, 2022 /PRNewswire/ -- The durian has been called the king of fruits, andThailand's vital cash cr...
2022-10-11 10:55
6364
Translumina further strengthens senior leadership to drive next phase of growth
NEW DELHI, Oct. 10, 2022 /PRNewswire/ -- Translumina - a global developer and manufacturer of innovative cardiovascular medical devices, implants and access products - appointedIndranil Mukherjee as Group CEO and Armin Kiser as Managing Director and Chief Operating Officer for the company'sEurope...
2022-10-10 21:35
3201
MAYBELLINE NY LAUNCHES FREE MENTAL HEALTH TRAINING IN COLLEGES
Brave Talk is a global college training program designed in partnership with mental health experts to give students the tools to support those around them experiencing anxiety or depression NEW YORK, Oct. 10, 2022 /PRNewswire/ -- More than half of first-year college students (54%) frequently ...
2022-10-10 21:00
4257
JW Therapeutics Announces NMPA Approval of Relmacabtagene Autoleucel Injection in Patients with Relapsed or Refractory Follicular Lymphoma
SHANGHAI, Oct. 10, 2022 /PRNewswire/ -- JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced that the National Medical Products Administration (NMPA) ofChina has approved ...
2022-10-10 20:00
4951
Pierre Fabre is taking a minority stake, via its dedicated investment subsidiary Pierre Fabre Invest, in Gennisium Pharma, an innovative company specializing in medicines for premature newborns and niche markets
* Gennisium finds a strategic partner with global experience and connections in the pharmaceutical industry to accelerate its development in neonatology. * Pierre Fabre strengthens its activities in the field of rare diseases, and more specifically pediatric ones. * This partnership paves th...
2022-10-10 15:00
2803
The China NMPA Approves Selpercatinib for the Treatment of Patients with RET-driven Lung and Thyroid Cancers
ROCKVILLE, Md. and SUZHOU, China, Oct. 10, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune, ophthalmology and o...
2022-10-10 08:23
4412
The China NMPA Approved CYRAMZA® (ramucirumab) for the Treatment in Patients with Hepatocellular Carcinoma
ROCKVILLE, Md. and SUZHOU, China, Oct. 10, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune, ophthalmology and o...
2022-10-10 08:20
3923
Ascletis Announces Dosing of 24 Healthy Subjects of the First 3 Cohorts in Multiple-Dose Escalation Phase I Clinical Trial of Oral RdRp Inhibitor ASC10 for COVID-19
--The multiple-dose escalation Phase I clinical trial will enroll 72 healthy subjects including 60 subjects in 6 dose escalation cohorts and 12 subjects in food effect trial. The enrollment is expected to be completed in the fourth quarter of 2022 --ASC10 is an oral double prodrug. After oral ...
2022-10-10 08:10
3269
Sciwind Biosciences Announces Initiation of Dosing in Phase 1 Clinical Trial Evaluating XW014, an oral small molecule GLP-1 receptor agonist for the Treatment of Obesity and Type 2 Diabetes
HANGZHOU, China and SAN FRANCISCO, Oct. 10, 2022 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat metabolic disease, announced today the initiation of dosing in a Phase 1 clinical trial ev...
2022-10-10 08:00
3523
WuXi Biologics Co., Ltd. Removed from Unverified List
WUXI, China, Oct. 10, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio", 2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that its subsidiary WuXi Biologics Co., Ltd. located in Wuxi city was removed from the Unverified List (UVL) by the U....
2022-10-10 07:55
5300
Mediterranean diet improves immunotherapy response rates and progression-free survival in advanced melanoma, new study presented at UEG Week suggests
VIENNA, Oct. 9, 2022 /PRNewswire/ -- Eating a Mediterranean diet, rich in fibre, mono-unsaturated fatty acids and polyphenols, has been associated with improved immunotherapy response rates and progression-free survival in advanced melanoma patients, a new study presented today at UEG Week 2022 h...
2022-10-09 06:01
2837
Everest Medicines Announces Approval of XERAVA® in Hong Kong for the Treatment of Complicated Intra-Abdominal Infections
SHANGHAI, Oct. 8, 2022 /PRNewswire/ -- Everest Medicines Limited (HKEX 1952.HK, "Everest Medicines", or the "Company"), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inAsia, annou...
2022-10-08 08:00
4141
Raffles Medical Group and NalaGenetics Provide Pre-emptive Genetic Testing for Adverse Drug Reactions
* Raffles is the first hospital in Singapore to provide pre-emptive pharmacogenomics testing protocol * Aims to reduce side effects due to inappropriate medications SINGAPORE, Oct. 7, 2022 /PRNewswire/ -- Raffles Medical Group (RMG) is collaborating with biotech start-up NalaGenetics to offer...
2022-10-07 17:22
3472
Week's Top Stories
Most Reposted
DayOne Files Registration Statement for Proposed Initial Public Offering
[Picked up by 276 media titles]
2026-10-06 05:28Zenika CTO Adrien Nortain Moves Base to Singapore to Strengthen Technical Leadership in Asia
[Picked up by 271 media titles]
2026-10-01 10:00
ViewSonic Launches VG1457 Dual-Screen Portable Monitor for Productivity Anywhere
[Picked up by 269 media titles]
2026-09-30 10:50
Vestas Powers Up Vietnam's Clean Energy Ambitions with Two New Projects Under PDP8 Totaling 16 Wind Turbines
[Picked up by 263 media titles]
2026-10-02 16:27
Sunway University to Host Asia's First Global Tipping Points Conference 2026
[Picked up by 263 media titles]
2026-09-30 12:11
Most Read
MixVio AI Launches Unified Creative Workspace Across 26 AI Generation Routes
2026-10-02 00:30
23821
